Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572097
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic HyperplasiaShanghai East HospitalNot Yet RecruitingNot Applicable
NCT07572097Not Yet Recruiting
Not Applicable
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prost...Shanghai East Hospital
NCT07573007
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and ComplicationsMarmara University Pendik Training and Research HospitalNot Yet Recruiting
NCT07573007Not Yet Recruiting
—
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and Comp...Marmara University Pendik...
NCT07572201
The Effect of Kinesio Taping Applied to the Gastrocnemius Muscle on Muscle Oxygenation, Pain Pressure Threshold, and Muscle Mechanical PropertiesOkan UniversityNot Yet RecruitingNot Applicable
NCT07572201Not Yet Recruiting
Not Applicable
The Effect of Kinesio Taping Applied to the Gastrocnemius Muscle on Muscle Oxyge...Okan University
NCT07574320
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel SyndromeMd. Aminul IslamNot Yet RecruitingPhase 4
NCT07574320Not Yet Recruiting
Phase 4
Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndr...Md. Aminul Islam
NCT07572994
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain SyndromeCairo UniversityNot Yet RecruitingNot Applicable
NCT07572994Not Yet Recruiting
Not Applicable
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatm...Cairo University
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573046
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic DisordersHospices Civils de LyonNot Yet Recruiting
NCT07573046Not Yet Recruiting
—
Validation Study of the ExéSem Battery Designed to Differentiate the Contributio...Hospices Civils de Lyon
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07573202
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to Evaluate Hypersensitivity Reactions in Shoulder SurgeryThe University of Texas Health Science Center, HoustonNot Yet RecruitingNot Applicable
NCT07573202Not Yet Recruiting
Not Applicable
Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh a Randomized Controlled Trial to...The University of Texas H...
NCT07574190
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South DakotaNot Yet RecruitingNot Applicable
NCT07574190Not Yet Recruiting
Not Applicable
A Mobile Web App Intervention to Promote Cervical Cancer ScreeningUniversity of South Dakot...
NCT07572409
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory StudymanxiaxiaRecruitingNot Applicable
NCT07572409Recruiting
Not Applicable
Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Singl...manxiaxia
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573839
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Using Sentiment Analysis Technology Based on Multi-modal Feature FusionShanghai Mental Health CenterRecruiting
NCT07573839Recruiting
—
An Exploratory Study on the Prediction of Recurrence Risk of Bipolar Disorder Us...Shanghai Mental Health Ce...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572526
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone HealthNot Yet RecruitingNot Applicable
NCT07572526Not Yet Recruiting
Not Applicable
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone Health
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573462
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsPfizerNot Yet RecruitingPhase 3
NCT07573462Not Yet Recruiting
Phase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy...Pfizer
Result Breakdown
Not yet recruiting14 (70%)
Recruiting5 (25%)
Unknown1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 12 (10%)
Phase 22 (10%)
Phase 41 (5%)
Phase 31 (5%)